3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
4
Breast Neoplasms
3
Ovarian Neoplasms
2
Lung Neoplasms
2
Fatigue
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Genital Neoplasms, Female
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Disease Progression
1
Colonic Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Bone Neoplasms
1
Adolescent and Young Adult Cancer Patient
1
Interventions
Paclitaxel
22
Carboplatin
18
liposomal doxorubicin
14
Bevacizumab
9
Topotecan
8
Docetaxel
8
Gemcitabine
7
Cisplatin
7
rucaparib
6
pembrolizumab
6
mirvetuximab soravtansine
5
Cyclophosphamide
5
Taxes
4
Albumin-Bound Paclitaxel
4
sargramostim
3
ixabepilone
3
Cytoreduction Surgical Procedures
3
CCV-AV protocol
3
130-nm albumin-bound paclitaxel
3
taxane
2
talazoparib
2
pazopanib
2
olaparib
2
fludarabine phosphate
2
fludarabine
2
denileukin diftitox
2
cediranib
2
catumaxomab
2
belinostat
2
avelumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Ovarian Epithelial
×
Palliative Care
×
Clear all
No trials found.